1.

Record Nr.

UNINA9910815060103321

Autore

Goethem Herman van <1958->

Titolo

Drancy-Auschwitz 1942-1944 : Jews from Belgium, deported via France / / Herman Van Goethem

Pubbl/distr/stampa

[Brussels, Belgium] : , : [Vubpress], , [2015]

©[2015]

ISBN

90-5718-097-9

Descrizione fisica

1 online resource (216 p.)

Disciplina

949.3004924

Soggetti

Jews, Belgian - France

Jews - Belgium

Holocaust, Jewish (1939-1945) - (1939-1945) - Belgium

Lingua di pubblicazione

Olandese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Description based upon print version of record.

Nota di contenuto

Pages:1 to 25; Pages:26 to 50; Pages:51 to 75; Pages:76 to 100; Pages:101 to 125; Pages:126 to 150; Pages:151 to 175; Pages:176 to 200; Pages:201 to 216



2.

Record Nr.

UNINA9911019428703321

Titolo

Protein kinases as drug targets / / edited by Bert Klebl, Gerhard Muller, and Michael Hamacher

Pubbl/distr/stampa

Weinheim, Germany, : Wiley-VCH, 2011

ISBN

9786613283245

9783527633494

3527633499

9781283283243

1283283247

9783527633470

3527633472

9783527633487

3527633480

Edizione

[2nd ed.]

Descrizione fisica

1 online resource (398 p.)

Collana

Methods and principles in medicinal chemistry ; ; v. 49

Altri autori (Persone)

MullerGerhard

KleblBert

HamacherMichael

Disciplina

615.19

Soggetti

Protein kinases

Drugs - Design

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Description based upon print version of record.

Nota di bibliografia

Includes bibliographical references and index.

Nota di contenuto

pt. 1. Hit finding and profiling for protein kinases : assay development and screening, libraries -- pt. 2. Medicinal chemistry -- pt. 3. Application of kinase inhibitors to therapeutic indication areas.

Sommario/riassunto

This timely guide to kinase inhibitor drug development is the first to cover the entire drug pipeline, from target identification to compound development and clinical application. Edited by the pioneers in the field, on the drug development side this ready reference discusses classical medicinal chemistry approaches as well as current chemical genomics strategies. On the clinical side, both current and future therapeutic application areas for kinase inhibitor drugs are addressed, with a strong focus on oncology drugs.Backed by recent clinical



experience with first-generation drugs in the b